<DOC>
	<DOCNO>NCT00146978</DOCNO>
	<brief_summary>Graft versus host disease ( GVHD ) major complication allogeneic bone marrow transplantation ( BMT ) , result death majority steroid resistant patient . The study design assess efficacy regional intra-arterial treatment patient resistant hepatic and/or gastro-intestinal GVHD .</brief_summary>
	<brief_title>Intra-Arterial Catheter Directed Therapy Severe Graft v . Host Disease ( GVHD )</brief_title>
	<detailed_description>Graft versus host disease ( GVHD ) ominous side effect allogeneic bone marrow blood stem cell transplantation ( BMT ) . GVHD cause severe inflammatory process , affect primarily skin GI ) system , include liver . Pharmacological treatment GVHD include various immunosuppressive immune-modulating drug , include steroid , cyclosporin , tacrolimus , methotrexate anti-lymphocyte agent . These agent aggravate immunologic incompetence , expose patient infection secondary malignancy , well reduce efficacy graft versus leukemia / graft versus tumor ( GVL / GVT ) effect induce alloreactive donor lymphocyte . In spite effect immune system , 50-70 % patient achieve partial control GVHD , rapidly deteriorate result death . Despite use innovative immunosuppressive modality , prognosis steroid resistant GVHD usually poor . GVHD mostly localize specific organ ( skin , liver , GI ) liver involvement tend chronic resistant . The bile duct main target GVHD , blood supply originate hepatic artery . This may explain ineffective nature oral steroid absorb gut portal vein . Sato et al report infusion steroid superior inferior mesenteric artery induce remission patient refractory GI GVHD . This method never test patient fulminant liver GVHD . We decide test approach large cohort patient steroid resistant hepatic intestinal GVHD . Patients eligible inclusion develop grade 3-4 hepatic and/or GI GVHD unresponsive treatment IV cyclosporin 3 mg/kg IV methylprednisolone ( MP ) 2 mg/kg . GVHD diagnosis base upon clinical criterion patient support biopsy . GVHD grade grade accord Seattle severity index . Patients hepatic GVHD first treat slow intra-arterial ( hepatic artery ) infusion methotrexate ( Pharmachemie , Netherland ) ( 10mg/m2 ) MP ( Pharmacia Upjohn , Belgium ) ( 75mg/m2 ) . The protocol later change exclusion methotrexate increase MP dose 1000mg . Patients GI GVHD treat intra-arterial ( SMA , IMA ) infusion MP ( 40-60 mg/vessel ) . In case upper GI GVHD intra-arterial infusion MP give gastro-duodenal artery ( GDA ) . Later , injection internal iliacs add . Technique Angiography perform use standard sterile technique , local anesthesia lidocaine 1 % conscious intravenous sedation . Visceral arteriography perform order determine anatomy identify variant arterial blood supply gut . A selection 3 - 5 Fr . angiographic catheter use discretion angiographer performing procedure . The frequently use catheter 4 Fr . &amp; 5 Fr . Cobra 2 Rim catheter ( Cook Inc. , Bloomington , In. ) . Other catheter use include Sos 2 ( Angiodynamics Inc. , Queensbury , NY . ) 3Fr . Terumo SP co-axial catheter ( Terumo Europe , N.V. , Leuven , Belgium. ) . Once catheter position , drug inject artery approximately three minute . After completion procedure , catheter remove direct manual pressure arteriotomy maintain hemostasis achieve . Patients remain complete bed rest involve extremity extend 6 hour , accordance standard angiographic practice . Compression device use . Definitions Hepatic response : initial response - day bilirubin level begin decrease , partial response - day bilirubin level decrease 70 % basal level , complete response - day bilirubin level decrease 30 % basal level . GI response : initial response - day symptom amelioration appear ( diarrhea volume abdominal pain ) . Complete response - day symptom resolve .</detailed_description>
	<mesh_term>Graft v Host Disease</mesh_term>
	<criteria>Recipient allogeneic stem cell transplantation . AGVHD liver GI tract , grade 24 . Resistant AGVHD . Signed write informed consent . Not fulfil inclusion criterion . Active lifethreatening infection . Inability comply study requirement . Contraindication arterial catheterization . Has diagnose multi organ failure .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>70 Years</maximum_age>
	<verification_date>March 2006</verification_date>
</DOC>